Can hemodialysis (HD) be performed on a patient with severe hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hemodialysis in Severe Hyponatremia (Sodium 110 mEq/L)

Yes, hemodialysis can be performed in patients with severe hyponatremia (sodium 110 mEq/L), but it requires specialized modifications to prevent catastrophic osmotic demyelination syndrome—specifically, using low-sodium dialysate (128 mEq/L, the lowest permissible level), reduced blood flow rates (starting at 50 mL/min), and meticulous monitoring to limit sodium correction to no more than 8 mmol/L per 24 hours. 1, 2

Critical Safety Framework

The fundamental danger is that conventional hemodialysis will correct sodium too rapidly, causing osmotic demyelination syndrome with permanent neurological damage or death. 2, 3 Standard dialysate contains 140-145 mEq/L sodium, which creates an enormous concentration gradient that will drive rapid sodium correction—exactly what must be avoided. 1, 2

Maximum Correction Rates

  • Never exceed 8 mmol/L correction in 24 hours to prevent osmotic demyelination syndrome 4
  • For high-risk patients (advanced liver disease, alcoholism, malnutrition), limit correction to 4-6 mmol/L per day 4
  • Target correction rate of 1 mEq/L per hour during the first HD session, then 2 mEq/L per hour in subsequent sessions 1

Modified Hemodialysis Protocol

Dialysate Modification

  • Use dialysate sodium concentration of 128 mEq/L (the lowest permissible level on conventional HD machines) 1
  • If conventional HD machines cannot achieve this, continuous venovenous hemofiltration (CVVH) with custom low-sodium replacement fluid is the preferred modality 2, 5

Blood Flow Rate Titration

  • Start with blood flow of 50 mL/min during the first session 1
  • Monitor sodium increase—should achieve approximately 1 mEq/L per hour 1
  • Increase to 100 mL/min for subsequent sessions if initial correction rate is appropriate 1
  • This achieves approximately 2 mEq/L per hour correction 1

Monitoring Protocol

  • Check serum sodium every 2 hours during dialysis sessions 4
  • Calculate total sodium correction from baseline—must not exceed 8 mmol/L in any 24-hour period 4, 1
  • Continue monitoring every 4 hours between dialysis sessions 4

Alternative: Continuous Renal Replacement Therapy

CVVH with low-sodium replacement fluid is technically superior for controlling sodium correction rate in severe hyponatremia with renal failure. 2, 5

CVVH Advantages

  • Allows precise control of sodium correction rate through single-pool sodium kinetic modeling 2
  • Can customize replacement fluid sodium concentration to match desired correction rate 2, 5
  • Provides continuous, gradual correction rather than intermittent rapid shifts 2, 5

CVVH Limitations

  • Not available in most resource-limited settings 1
  • Requires ICU-level care and specialized equipment 2
  • When CVVH is unavailable, modified conventional HD is an acceptable alternative 1

Addressing Uremic Complications

The patient likely requires dialysis for advanced azotemia, fluid overload, and uremic symptoms (vomiting, altered mental status). 1

Balancing Competing Priorities

  • Uremic symptoms require urgent dialysis, but rapid sodium correction risks osmotic demyelination 1
  • The modified HD protocol addresses both: blood flow of 50-100 mL/min provides adequate uremic clearance while limiting sodium correction 1
  • Complete resolution of uremic manifestations is achievable within 48 hours using this approach 1

Theoretical Protective Effect of Uremia

Uremia may provide partial protection against osmotic demyelination during rapid sodium correction. 3

Mechanism

  • Urea diffuses slowly across the blood-brain barrier, acting as an effective osmole 3
  • During HD, blood urea drops rapidly, potentially causing cerebral edema (dialysis disequilibrium syndrome) 3
  • This cerebral edema may counteract the fluid shift out of the brain during sodium correction 3

Clinical Significance

  • Case reports demonstrate successful rapid correction without neurological damage in uremic patients 3
  • However, this protection is theoretical and unreliable—the standard 8 mmol/L per 24-hour limit must still be observed 4, 3

Common Pitfalls to Avoid

  • Never use standard dialysate (140-145 mEq/L sodium) in severe hyponatremia—this guarantees overcorrection 1, 2
  • Never prioritize rapid uremic clearance over sodium correction safety—modified protocols achieve both 1
  • Never assume uremia provides complete protection against osmotic demyelination—follow correction rate limits 4, 3
  • Inadequate monitoring during active correction leads to unrecognized overcorrection 4

Post-Dialysis Management

After achieving sodium >120-125 mEq/L and resolving uremic symptoms:

  • Implement fluid restriction to 1-1.5 L/day if hypervolemic hyponatremia persists 4
  • Discontinue diuretics until sodium normalizes 4
  • Continue monitoring sodium levels daily 4
  • Watch for signs of osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) typically occurring 2-7 days after correction 4

References

Research

Successful management of severe hyponatremia in CKD-VD: In a cost limited setting.

Hemodialysis international. International Symposium on Home Hemodialysis, 2019

Research

Treatment of severe hyponatremia in patients with kidney failure: role of continuous venovenous hemofiltration with low-sodium replacement fluid.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Successful treatment of severe hyponatremia in a patient with renal failure using continuous venovenous hemodialysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.